Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update

Eloxx Pharmaceuticals (ELOX) Misses Q2 EPS by 2c

August 15, 2022 8:05 AM EDT

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

... More